Understanding how a protein complex affects mRNA decay in cancer cells
Investigating the role of the Ccr4-Not complex in regulating codon optimality-mediated mRNA decay
This study is looking at a special protein complex that helps control how quickly certain messages in our cells break down, which is important for making proteins, and it hopes to find new ways to help treat conditions like acute T-cell leukemia by understanding how this process works.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10899510 on NIH RePORTER |
What this research studies
This research investigates the Ccr4-Not complex, which plays a crucial role in regulating the decay of messenger RNA (mRNA) that is linked to the translation of proteins. By examining how this complex interacts with ribosomes during protein synthesis, the study aims to uncover mechanisms that could lead to disruptions in mRNA decay, potentially contributing to conditions like acute T-cell leukemia. The research employs advanced techniques to dissect the interactions and functions of this complex, which may reveal new therapeutic targets for cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with acute T-cell leukemia or related hematological malignancies.
Not a fit: Patients with solid tumors or those not diagnosed with acute T-cell leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating acute T-cell leukemia and other related cancers by targeting the mRNA decay process.
How similar studies have performed: Previous research has shown that targeting mRNA decay mechanisms can be effective in treating certain cancers, suggesting that this approach may hold promise.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Christensen, Lana Nicole — Johns Hopkins University
- Study coordinator: Christensen, Lana Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.